Farydak

Medicinal product

(Invented) name

Farydak

Active substance (s)

Panobinostatas

Strength

20 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XH03, panobinostat

Marketing authorisation holder

pharmaand GmbH, Austrija

Date of authorisation

2015-08-28

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Capsule, hard	1 vnt.
Panobinostatas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
63416	77855	1077855	lizdinė plokštelė	N6		Receptinis	EU/1/15/1023/007	Netiekiama	-	-	No	-	-
63417	77856	1077856	lizdinė plokštelė	N12		Receptinis	EU/1/15/1023/008	Netiekiama	-	-	No	-	-
63418	77857	1077857	lizdinė plokštelė	N24		Receptinis	EU/1/15/1023/009	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2015-08-28	Registruotas